Tal Nuriel

Columbia University Irving Medical Center — United States

Medicine · Health Sciences

15h-index2.5kcitations50works4.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(17), Dementia and Cognitive Impairment Research(7), Metabolomics and Mass Spectrometry Studies(6), Nitric Oxide and Endothelin Effects(5), S100 Proteins and Annexins(4)

Publications50 total

APOE4 alters the regional levels of numerous neuroimaging biomarkers across the Alzheimer's disease continuum
Alzheimer s & Dementia·2025Open Access
Spatially distinct accretion of docosahexaenoic acid and eicosapentaenoic acid in a mouse model of Alzheimer's disease prior to plaque deposition
Alzheimer s & Dementia·2025Open Access
APOE Genotype Modulates Tau Propagation in A Novel Humanized Mouse Model of Early‐Stage Alzheimer's Disease
Alzheimer s & Dementia·2025Open Access
Investigating the Effects of <i>APOE</i> Genotype on Intracellular Cholesterol and the Endolysosomal System in the Aging Mouse Brain
2025Open Access
Focused ultrasound‐mediated <i>APOE4</i> knockdown in mouse brain
Alzheimer s & Dementia·2025· 2 citedOpen Access
Selective removal of astrocytic PERK protects against glymphatic impairment and decreases toxic aggregation of β-amyloid and tau
Neuron·2025· 11 cited
<i>APOE-</i> ε4-induced Fibronectin at the blood-brain barrier is a conserved pathological mediator of disrupted astrocyte-endothelia interaction in Alzheimer’s disease
2025· 7 citedOpen Access
Investigating the APOE4‐associated heterogeneity of imaging biomarkers across AD diagnostic stages
Alzheimer s & Dementia·2024Open Access
Rare genetic variation in fibronectin 1 (<i>FN1</i>) protects against <i>APOE</i> ɛ4 in Alzheimer’s Disease
Alzheimer s & Dementia·2024Open Access
APOE4 Alters Tau Propagation in Regions Associated with Early Alzheimer’s Disease in a Humanized Mouse Model of Tau Spread
Alzheimer s & Dementia·2024Open Access
Commonalities in the lipid profile shift in ApoE ε4 risk variant and mild cognitive impairment highlight acyl chain remodeling
Alzheimer s & Dementia·2024Open Access
<i>APOE</i> ε4–associated heterogeneity of neuroimaging biomarkers across the Alzheimer's disease continuum
Alzheimer s & Dementia·2024· 5 citedOpen Access
Editorial: APOE4-associated heterogeneity in the pathogenesis of Alzheimer's disease
Frontiers in Aging Neuroscience·2024· 1 citedOpen Access
Corrigendum: Brain and serum lipidomic profiles implicate Lands cycle acyl chain remodeling association with APOEε4 and mild cognitive impairment
Frontiers in Aging Neuroscience·2024Open Access
Brain and serum lipidomic profiles implicate Lands cycle acyl chain remodeling association with APOEε4 and mild cognitive impairment
Frontiers in Aging Neuroscience·2024· 4 citedOpen Access
Rare genetic variation in fibronectin 1 (FN1) protects against APOEε4 in Alzheimer’s disease
Acta Neuropathologica·2024· 46 citedOpen Access
A pharmacological toolkit for human microglia identifies Topoisomerase I inhibitors as immunomodulators for Alzheimer’s disease
2024· 16 citedOpen Access
A Pharmacological Toolkit for Human Microglia Identifies Topoisomerase I Inhibitors as Immunomodulators for Alzheimer's Disease
SSRN Electronic Journal·2024Open Access
A Pharmacological Toolkit for Human Microglia Identifies Topoisomerase I Inhibitors as Immunomodulators for Alzheimer's Disease
SSRN Electronic Journal·2024· 2 citedOpen Access
Intracellular cholesterol visualization in brain tissue using D4H∗
STAR Protocols·2023· 5 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Steven S. Gross(12), Karen Duff(9), Helen Y. Figueroa(8), Vilas Menon(8), Jason Mares(8), Hirra A. Arain(7), Archana Ashok(6), Prabesh Bhattarai(6), Çağhan Kızıl(6), Laura Beth McIntire(5), Juan Idiarte(5), Jia Guo(5), Katerina Akassoglou(4), Mathieu Herman(4), Mark Cookson(4), Ruba S. Deeb(4), Estela Área-Gómez(4), Verena Haage(4), Philip L. De Jager(4), William Jones Dartora(4)